Go to Wolters Kluwer VitalLaw.comGo to Wolters Kluwer VitalLaw.com
VitalLaw®
  • Find answers to your questions
  • Log in to access your subscriptions
In depth. On point.
In depth. On point.
  • Home
  • Legal Directory
  • Home
  • Legal Directory
In depth. On point.
  • Articles
  • Articles
  • Law Firms
  • Law Firms
  • Organizations
  • Organizations
    • TOP STORY—2d Cir.: Preliminary injunction barring “forced switch” to reformulated Namenda upheld
    • ADVERTISING—C.D. Cal.: False advertising claims against health and beauty products manufacturer dismissed
    • ADVERTISING—W.D. Wash.: Lanham Act claim based on statement on yarn company website fails
    • ANTITRUST NEWS: European Commission issues statement of objections to Grupo Riberebro Integral S.L.
    • ANTITRUST NEWS: FTC recommends tactics to make pet medication industry more competitive
    • ANTITRUST NEWS: Teva agrees to $1.2B settlement in FTC suit over Provigil agreements
    • ANTITRUST NEWS: The Swedish Competition Authority takes action against Nasdaq OMX for abuse of dominant market position
    • ANTITRUST—2d Cir.: Denial of Apple’s efforts to remove current antitrust compliance monitor in e-book case upheld
    • BLOG TRACKER—Noteworthy blog posts and other commentary
    • CONSUMER PROTECTION NEWS: FCC Chairman proposes tighter restrictions on robocalls, autodialers
    • FRANCHISING & DISTRIBUTION NEWS: Office products distributors seek declaration, injunction against franchisor
    • FRANCHISING & DISTRIBUTION—D. Haw.: Harley distributor considered a franchise for Franchise Investment Law purposes
    • RICO—E.D. Mich.: State Farm moves forward with fraudulent billing claims
    • STATE UNFAIR TRADE PRACTICES—N.D. Ill.: Alternative Retail Electric Suppliers rate claim dismissed
  • Articles
  • Articles
  • Law Firms
  • Law Firms
  • Organizations
  • Organizations

    Antitrust Law Daily Wrap Up, ANTITRUST NEWS: European Commission issues statement of objections to Grupo Riberebro Integral S.L., (May 28, 2015)

    By Michael Menzhuber, J.D., LL.M.

    The European Commission (EC) has sent a statement of objections to Grupo Riberebro Integral S.L., and its subsidiary Riberebro Integral S.A.U., that it suspects the companies of having breached European Union (EU) antitrust rules by colluding with co ...

    By Michael Menzhuber, J.D., LL.M.

    The European Commission (EC) has sent a statement of objections to Grupo Riberebro Integral S.L., and its subsidiary Riberebro Integral S.A.U., that it suspects the companies of having breached European Union (EU) antitrust rules by colluding with competitors on both customer allocation and the pricing of so-called "private label" canned mushrooms (i.e. manufactured by one company to be sold under another company's brand name) in the European Economic Area (EEA). This activity violates EU rules that prohibit anti-competitive business practices such as collusion on prices and market sharing (Article 101 of the Treaty on the Functioning of the European Union and Article 53 of the EEA Agreement).

    The EC’s investigation started with unannounced inspections in February 2012. In June 2014, a settlement decision was adopted against three companies (Bonduelle, Lutèce and Prochamp) that admitted their involvement in the cartel. The total fines imposed were €32,225,000. The investigation concerning Riberebro continued under the standard cartel procedure.

    If, after the companies have exercised their rights of defense, the EC concludes that there is sufficient evidence of an infringement, it can adopt a decision prohibiting the conduct and imposing a fine of up to 10 percent of a company's annual worldwide turnover.

    News: Antitrust

    © 2026 CCH Incorporated and its affiliates and licensors. All rights reserved.

    • Manage Cookie Preferences
    • Privacy Statement
    • Terms of Use